156 related articles for article (PubMed ID: 7842362)
1. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge.
Rak S; Jacobson MR; Sudderick RM; Masuyama K; Juliusson S; Kay AB; Hamid Q; Löwhagen O; Durham SR
Clin Exp Allergy; 1994 Oct; 24(10):930-9. PubMed ID: 7842362
[TBL] [Abstract][Full Text] [Related]
2. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.
Masuyama K; Jacobson MR; Rak S; Meng Q; Sudderick RM; Kay AB; Lowhagen O; Hamid Q; Durham SR
Immunology; 1994 Jun; 82(2):192-9. PubMed ID: 7927488
[TBL] [Abstract][Full Text] [Related]
3. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
[TBL] [Abstract][Full Text] [Related]
4. Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: effect of topical corticosteroids.
Masuyama K; Till SJ; Jacobson MR; Kamil A; Cameron L; Juliusson S; Lowhagen O; Kay AB; Hamid QA; Durham SR
J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):610-7. PubMed ID: 9802369
[TBL] [Abstract][Full Text] [Related]
5. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy.
Ghaffar O; Laberge S; Jacobson MR; Lowhagen O; Rak S; Durham SR; Hamid Q
Am J Respir Cell Mol Biol; 1997 Jul; 17(1):17-24. PubMed ID: 9224205
[TBL] [Abstract][Full Text] [Related]
6. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis.
Weido AJ; Reece LM; Alam R; Cook CK; Sim TC
Ann Allergy Asthma Immunol; 1996 Nov; 77(5):407-15. PubMed ID: 8933780
[TBL] [Abstract][Full Text] [Related]
7. Effect of fluticasone propionate aqueous nasal spray on allergen-induced inflammatory changes in the nasal airways of allergic rhinitics following exposure to nitrogen dioxide.
Wang JH; Devalia JL; Rusznak C; Bagnall A; Sapsford RJ; Davies RJ
Clin Exp Allergy; 1999 Feb; 29(2):234-40. PubMed ID: 10051728
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte/macrophage-colony stimulating factor in allergen-induced rhinitis: cellular localization, relation to tissue eosinophilia and influence of topical corticosteroid.
Nouri-Aria KT; Masuyama K; Jacobson MR; Rak S; Lowhagen O; Schotman E; Hamid Q; Durham S
Int Arch Allergy Immunol; 1998 Dec; 117(4):248-54. PubMed ID: 9876226
[TBL] [Abstract][Full Text] [Related]
9. Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge.
Erin EM; Zacharasiewicz AS; Nicholson GC; Tan AJ; Higgins LA; Williams TJ; Murdoch RD; Durham SR; Barnes PJ; Hansel TT
Clin Exp Allergy; 2005 Dec; 35(12):1608-14. PubMed ID: 16393327
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitics.
Di Lorenzo G; Gervasi F; Drago A; Esposito Pellitteri M; Di Salvo A; Cosentino D; Potestio M; Colombo A; Candore G; Mansueto S; Caruso C
Clin Exp Allergy; 1999 Oct; 29(10):1367-77. PubMed ID: 10520057
[TBL] [Abstract][Full Text] [Related]
11. Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid.
Bradding P; Feather IH; Wilson S; Holgate ST; Howarth PH
Am J Respir Crit Care Med; 1995 Jun; 151(6):1900-6. PubMed ID: 7767538
[TBL] [Abstract][Full Text] [Related]
12. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis.
Foresi A; Pelucchi A; Gherson G; Mastropasqua B; Chiapparino A; Testi R
J Allergy Clin Immunol; 1996 Aug; 98(2):274-82. PubMed ID: 8757203
[TBL] [Abstract][Full Text] [Related]
13. Mast cells and mediators in the nasal mucosa after allergen challenge. Effects of four weeks' treatment with topical glucocorticoid.
Juliusson S; Holmberg K; Karlsson G; Enerbäck L; Pipkorn U
Clin Exp Allergy; 1993 Jul; 23(7):591-9. PubMed ID: 7693314
[TBL] [Abstract][Full Text] [Related]
14. A double-blind comparison of fluticasone propionate aqueous nasal spray, terfenadine tablets and placebo in the treatment of patients with seasonal allergic rhinitis to grass pollen.
Darnell R; Pecoud A; Richards DH
Clin Exp Allergy; 1994 Dec; 24(12):1144-50. PubMed ID: 7889428
[TBL] [Abstract][Full Text] [Related]
15. Expression of IL-16 in allergen-induced late-phase nasal responses and relation to topical glucocorticosteroid treatment.
Laberge S; Durham SR; Ghaffar O; Rak S; Center DM; Jacobson M; Hamid Q
J Allergy Clin Immunol; 1997 Oct; 100(4):569-74. PubMed ID: 9338554
[TBL] [Abstract][Full Text] [Related]
16. Intranasal fluticasone propionate reduces ICAM-1 on nasal epithelial cells both during early and late phase after allergen challenge.
Ciprandi G; Ricca V; Passalacqua G; Fasolo A; Canonica GW
Clin Exp Allergy; 1998 Mar; 28(3):293-9. PubMed ID: 9543078
[TBL] [Abstract][Full Text] [Related]
17. Expression of IL-4, Cepsilon RNA, and Iepsilon RNA in the nasal mucosa of patients with seasonal rhinitis: effect of topical corticosteroids.
Cameron LA; Durham SR; Jacobson MR; Masuyama K; Juliusson S; Gould HJ; Lowhagen O; Minshall EM; Hamid QA
J Allergy Clin Immunol; 1998 Mar; 101(3):330-6. PubMed ID: 9525448
[TBL] [Abstract][Full Text] [Related]
18. Preventive treatment of intranasal fluticasone propionate reduces cytokine mRNA expressing cells before and during a single nasal allergen provocation.
Kleinjan A; Holm AF; Dijkstra MD; Boks SS; Severijnen L; Mulder PG; Fokkens WJ
Clin Exp Allergy; 2000 Oct; 30(10):1476-85. PubMed ID: 10998026
[TBL] [Abstract][Full Text] [Related]
19. Nasal cytological changes following pharmacological intervention.
Meltzer EO
Allergy; 1995; 50(23 Suppl):15-20. PubMed ID: 7604949
[TBL] [Abstract][Full Text] [Related]
20. Increased number of CD34+ cells in nasal mucosa of allergic rhinitis patients: inhibition by a local corticosteroid.
Sergejeva S; Malmhäll C; Lötvall J; Pullerits T
Clin Exp Allergy; 2005 Jan; 35(1):34-8. PubMed ID: 15649263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
